Spero licenses anti-CD40L antibody from Innovent for $1.1bn
Spero Therapeutics, a US biotech company, has licensed an antibody from Innovent for $1.1 billion. This antibody is used to treat diseases. The company will use this antibody to develop new treatments.
5.5Significance
1 source5.0Source trust